Results 121 to 130 of about 20,782 (204)

Oestradiol concentrations in trans women with HIV suppressed on unboosted integrase inhibitor regimens versus trans women without HIV taking oral oestradiol: a pilot study. [PDF]

J Antimicrob Chemother, 2023
Loutfy M, Lacombe-Duncan A, Tseng A, Persad Y, Underhill A, Kennedy VL, Armstrong I, Fung R, Bourns A, Nguyen Q, Hranilovic S, Weisdorf T, Chan LYL, Kia H, Halpenny R, Iyer H, Jeyarajah N, Kovchazov G, McCully J, Scarsi KK.   +19 more
europepmc   +1 more source

Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor. [PDF]

ACS Med Chem Lett, 2022
Parcella K, Parcella K, Wang T, Eastman K, Zhang Z, Yin Z, Patel M, Tu Y, Zheng BZ, Walker MA, Saulnier MG, Frennesson D, Bowsher M, Gillis E, Peese K, Belema M, Cianci C, Dicker IB, McAuliffe B, Ding B, Falk P, Simmermacher J, Parker DD, Sivaprakasam P, Kish K, Lewis H, Hanumegowda U, Jenkins S, Kadow JF, Krystal M, Meanwell NA, Naidu BN.   +31 more
europepmc   +1 more source

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance [PDF]

, 2012
Mark A. Wainberg
openalex   +1 more source

Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy. [PDF]

AIDS, 2022
Vakili S, Paneru B, Guerrier CM, Miller J, Baumrin E, Forrestel A, Lynn K, Frank I, Lo Re V, Collman RG, Hill DA.   +10 more
europepmc   +1 more source

Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy. [PDF]

Open Forum Infect Dis
Hulgan T, Erlandson KM, Bradford Y, Tassiopoulos K, Wu K, Bares SH, Brown TT, Lake JE, Leonard M, McComsey GA, Ritchie MD, Sax PE, Koethe JR, Haas DW.   +13 more
europepmc   +1 more source

High Baseline Viremia: An Achilles Heel for Integrase Inhibitor-Based Antiretroviral Therapy? [PDF]

Clin Infect Dis, 2021
McCluskey SM, Marconi VC.
europepmc   +1 more source

Erratum for Dinh et al., "The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir". [PDF]

mBio
Dinh T, Tber Z, Rey JS, Mengshetti S, Annamalai AS, Haney R, Briganti L, Amblard F, Fuchs JR, Cherepanov P, Kim K, Schinazi RF, Perilla JR, Kim B, Kvaratskhelia M.   +14 more
europepmc   +1 more source

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens. [PDF]

Clin Infect Dis, 2021
Leonard MA, Cindi Z, Bradford Y, Bourgi K, Koethe J, Turner M, Norwood J, Woodward B, Erdem H, Basham R, Baker P, Rebeiro PF, Sterling TR, Hulgan T, Daar ES, Gulick R, Riddler SA, Sinxadi P, Ritchie MD, Haas DW.   +19 more
europepmc   +1 more source

332. Exploring the Prevalence and Characteristics of Weight Gain and other Metabolic Changes in Patients with HIV Infection Switching to Integrase Inhibitor Containing ART [PDF]

, 2019
Matty Zimmerman, Joseph DeSimone, Jason J. Schafer   +2 more
openalex   +1 more source

Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus. [PDF]

AIDS Res Hum Retroviruses, 2022
Asundi A, Olson A, Jiang W, Varshney SP, White LF, Sagar M, Lin NH.   +6 more
europepmc   +1 more source